Meeting Jeremy Sturgess-Smith of Ananda Pharma plc: Cannabis, Clinical Trials & Courting Gen Z

Meet Jeremy Sturgess-Smith of UK-based company, Ananda Pharma.

💡 Meet Jeremy Sturgess-Smith of UK-based company, Ananda Pharma Plc. While at the 2025

Master Investor

Show, I caught up with Jeremy, Ananda’s Finance Director. Very helpful to get the scoop on Ananda, especially given the important, life-improving work they are doing.

As an aside: If Orlando Bloom and Adrian Brody had a finance-savvy cousin explaining clinical trials at a company stand — that’d be Jeremy! 😆

We talked:
Cannabis (the clinical kind) 🌿, commitment (the shareholder kind) 📈, and communication (the Gen Z kind) 📱.

Here’s what he spilled:

🧠 Two Phase 3 trials for drug-resistant epilepsy

⚡Phase 2 trials for nerve pain and endometriosis 🩺

💼 The Ananda leadership team all have ‘skin in the game’ and are shareholders themselves

Plus, a their slick approach to bringing retail investors, including younger generations into their hub with ongoing presenations, Q&As, webinars & videos — all QR-coded for your convenience 🔍

They’re not just developing plant-based medicine — they’re redefining investor engagement for the digital age.

#TEAwith #AnandaPharma #RetailInvestors #GenZFinance #CannabisScience #TEACupsHonours #MasterInvestorShow #CorporateGovernance #InvestorRelations #FinanceWithFlair #TEAwithSherylC